PhiChem Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Operating Revenue	3,070	2,899	2,713	2,863	2,607	1,840
Other Revenue	18.51	18.51	15.61	43.34	20.32	24.18
Revenue	3,089	2,918	2,729	2,907	2,627	1,864
Revenue Growth (YoY)	6.48%	6.92%	-6.13%	10.65%	40.94%	23.18%
Cost of Revenue	2,013	1,913	1,792	1,765	1,582	1,131
Gross Profit	1,075	1,005	936.4	1,142	1,045	732.92
Selling, General & Admin	446.89	433.18	438.35	395.77	337.22	273.32
Research & Development	193.94	181.65	189.24	183.69	192.74	136.39
Other Operating Expenses	33.48	10.89	7.3	20.19	23.35	18.06
Operating Expenses	683.06	657.5	655.06	601.71	561.37	430.96
Operating Income	392.23	347.36	281.34	540.27	483.54	301.96
Interest Expense	-29.73	-44.83	-56.31	-59.06	-66.63	-76.41
Interest & Investment Income	73.51	57.48	57.17	22.05	89.17	8.06
Currency Exchange Gain (Loss)	3.47	3.47	2.81	13.02	-3.49	-4.51
Other Non Operating Income (Expenses)	-11.41	-9.88	-159.95	-8.9	-11.13	-8.04
EBT Excluding Unusual Items	428.07	353.6	125.06	507.38	491.45	221.07
Impairment of Goodwill	-	-	-	-1.48	-1.55	-1.51
Gain (Loss) on Sale of Investments	-11.08	-53.05	5.26	-26.78	-32.93	30.84
Gain (Loss) on Sale of Assets	-12.45	-1.51	0	0.13	-1.05	-0.69
Asset Writedown	-15.33	-12.55	-1	-1.57	-2.66	-1.06
Other Unusual Items	24.52	18.43	21.93	15.42	21.16	26.26
Pretax Income	413.73	304.93	151.24	493.11	474.41	274.91
Income Tax Expense	58.99	32.56	15.43	49.57	73.45	35.72
Earnings From Continuing Operations	354.74	272.37	135.81	443.54	400.96	239.18
Minority Interest in Earnings	-23.14	-25.84	-23.46	-8.97	-15.1	-9.35
Net Income	331.61	246.53	112.35	434.57	385.87	229.83
Net Income to Common	331.61	246.53	112.35	434.57	385.87	229.83
Net Income Growth	207.03%	119.42%	-74.15%	12.62%	67.89%	-9.92%
Shares Outstanding (Basic)	540	525	535	517	514	511
Shares Outstanding (Diluted)	540	525	535	517	514	511
Shares Change (YoY)	0.67%	-1.96%	3.42%	0.56%	0.73%	0.09%
EPS (Basic)	0.61	0.47	0.21	0.84	0.75	0.45
EPS (Diluted)	0.61	0.47	0.21	0.84	0.75	0.45
EPS Growth	204.97%	123.81%	-75.00%	12.00%	66.67%	-10.00%
Free Cash Flow	129.7	413.89	19.06	202.31	-10.85	-92.75
Free Cash Flow Per Share	0.24	0.79	0.04	0.39	-0.02	-0.18
Dividend Per Share	0.105	0.095	0.080	0.080	0.070	0.065
Dividend Growth	-4.54%	18.75%	-	14.29%	7.69%	-
Gross Margin	34.82%	34.44%	34.32%	39.29%	39.77%	39.32%
Operating Margin	12.70%	11.91%	10.31%	18.59%	18.41%	16.20%
Profit Margin	10.74%	8.45%	4.12%	14.95%	14.69%	12.33%
Free Cash Flow Margin	4.20%	14.19%	0.70%	6.96%	-0.41%	-4.98%
EBITDA	581.6	531.66	458.88	685.88	604.68	407.26
EBITDA Margin	18.83%	18.22%	16.82%	23.59%	23.02%	21.85%
D&A For EBITDA	189.37	184.3	177.54	145.61	121.14	105.3
EBIT	392.23	347.36	281.34	540.27	483.54	301.96
EBIT Margin	12.70%	11.91%	10.31%	18.59%	18.41%	16.20%
Effective Tax Rate	14.26%	10.68%	10.20%	10.05%	15.48%	13.00%
Revenue as Reported	3,089	2,918	2,729	2,907	2,627	1,864
Advertising Expenses	-	1.26	7.13	1.24	3.15	0.37

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.